Navigation Links
US FDA Grants Orphan Drug Status to Immtech's Pafuramidine for Treatment of African Sleeping Sickness
Date:9/19/2007

NEW YORK, Sept. 19 /PRNewswire-FirstCall/ -- Immtech Pharmaceuticals, Inc. (Amex: IMM) announced today that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to pafuramidine (DB289) for treating Human African Trypanosomiasis (HAT), also known as African sleeping sickness. Orphan drug designation provides Immtech with numerous financial and regulatory benefits during pafuramidine's development, including government grants for conducting clinical trials, waiver of New Drug Application submission fees, tax credits, and a seven-year market exclusivity upon final FDA approval.

Pafuramidine is currently in phase III clinical trials for African sleeping sickness at six trial sites in Africa. The infectious disease, spread by tsetse flies, threatens approximately 60 million people in over 30 countries in sub-Saharan Africa. Current treatments for the disease are associated with high levels of toxicity and are difficult to administer. Safety data for pafuramidine has been positive to date, and the FDA and Ethics Committees responsible for the study oversight currently allow adolescents, pregnant women and nursing mothers to participate in these clinical trials. These groups are particularly vulnerable to the disease.

"The FDA's decision reflects the significant need for new treatments for African sleeping sickness," stated Carol Olson, MD, PhD, Immtech's Sr. Vice President and Chief Medical Officer. "Pafuramidine has the potential to be the first oral treatment for this fatal and neglected disease. Patients often put off screening and treatment because current drugs must be given by injection. A safe and effective pill that is readily available should facilitate cure for more patients i
'/>"/>

SOURCE Immtech Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Sirion Therapeutics Receives Orphan Drug Designation for Ophthalmic Drug to Treat Viral Eye Infection
2. Allos Therapeutics PDX Granted Orphan Medicinal Product Designation by the European Commission
3. DUSA Pharmaceuticals Receives Orphan Drug Desi gnation for Levulan PDT to Treat Esophage al Dysplasia
4. AOP Orphan Pharmaceuticals and Lantibio Announce Positive Phase II Study with Novel Cystic Fibrosis Therapy
5. Point of Care Strep Tests Speed Treatment, Lower Costs
6. Rapid HIV Testing Increases Possibility of Treatment
7. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
8. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
11. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... Tianyin Pharmaceutical Co., Inc. (NYSE Amex: ... specializes in patented biopharmaceutical, modernized traditional Chinese medicine ... today updates the timeline for the GMP certification ... The Company is scheduled to submit the ... & Drug Administration,s (CFDA) review in the week ...
(Date:8/28/2014)... SALT LAKE CITY , Aug. 28, 2014 /PRNewswire-iReach/ ... in 2000 by service academy graduates, has published a ... its concentrated, three-day Leadership Excellence Course . In ... the  Leadership Excellence Course to Albuquerque , ... Tucson . Photo - http://photos.prnewswire.com/prnh/20140828/140814 ...
(Date:8/28/2014)... Nonin Medical, Inc., the inventor of finger ... today announced that the Food and Drug Administration (FDA) ... oximeter for use in the United States ... telemedicine hub or kiosk through a USB connector and ... adult patients. The Model 3231 received EU certification last ...
Breaking Medicine Technology:TPI Submits Dataset for GMP Inspection at Qionglai Facility (QLF) 2Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 2Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 3Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 4Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 5Nonin Medical Announces FDA Clearance of Nonin Model 3231 USB Pulse Oximeter 2
... Xenogenics Corporation ("Xenogenics"), a majority owned subsidiary of ... to announce it has retained the Emmes Group to ... formation strategy to help finance expanded human clinical trials ... testing and initial human use, the Ideal BioStent™ demonstrated ...
... Biosciences, a privately held company leading the development of ... McDonald, MBA, Senior Vice President and Chief Business Officer, ... will highlight new and innovative cardiovascular drug therapies at ... discussion will be held at the New York Palace ...
Cached Medicine Technology:Xenogenics Corporation Retains the Emmes Group to Advise on Fund Raising Efforts 2Xenogenics Corporation Retains the Emmes Group to Advise on Fund Raising Efforts 3Xenogenics Corporation Retains the Emmes Group to Advise on Fund Raising Efforts 4Regado Biosciences to Present at the 2011 RBC Capital Markets Healthcare Conference in New York City 2Regado Biosciences to Present at the 2011 RBC Capital Markets Healthcare Conference in New York City 3
(Date:8/29/2014)... HealthDay Reporter , THURSDAY, Aug. 28, ... days of the Ebola outbreak in West Africa has given ... Researchers report in the Aug. 28 online issue of ... The Ebola strains responsible for the current outbreak ... first recorded outbreak of Ebola in central Africa in 1976. ...
(Date:8/29/2014)... Winston-Salem, N.C (PRWEB) August 29, 2014 ... 13 awards for excellence in clinical care, honoring nine ... improving the patient experience. , “At Novant Health, providing ... a top priority” said Tom Zweng, MD, executive vice ... continued commitment to provide a remarkable experience for each ...
(Date:8/29/2014)... Bedros Keuilian recently stepped outside his comfort zone to ... the new Spike TV reality show, Gym Rescue. The producers ... an expert in boot camp marketing and Google directed them ... just released a webinar explaining how fitness boot camp owners ... and increase their client base. , In the hour-long ...
(Date:8/29/2014)... Pittsburgh, PA (PRWEB) August 29, 2014 "I ... four neck surgeries, as well as many other surgeries in ... inventor from Richmond, Texas. "During my stays, I was unable ... and many other ailments. Two nurses freely had to physically ... stood on either side of me and pulled the sheets. ...
(Date:8/29/2014)... 2014 Gwyneth Paltrow, Beyonce and Angelina Jolie ... have inspired dieters all over the United States, to find ... to help them quickly shed excess fat. And, recent inspiration ... that substitutes all gluten products, eggs and meats for ingredients ... associated with following this type of diet, one must be ...
Breaking Medicine News(10 mins):Health News:Gene Research Yields Insights Into Ebola Virus 2Health News:Gene Research Yields Insights Into Ebola Virus 3Health News:Novant Health Recognized for Excellence in Clinical Care 2Health News:Novant Health Recognized for Excellence in Clinical Care 3Health News:Boot Camp Marketing Expert Bedros Keuilian Releases New Webinar on Using YouTube to Build Credibility and Clientele 2Health News:Boot Camp Marketing Expert Bedros Keuilian Releases New Webinar on Using YouTube to Build Credibility and Clientele 3Health News:InventHelp® Client Develops Equipment for Surgical and Bedridden Patients (HCD-279) 2Health News:Diet Doc Announces Diet Plans that Deliver Fast Weight Loss Results at a Fraction of the Cost of Celebrity Diets 2Health News:Diet Doc Announces Diet Plans that Deliver Fast Weight Loss Results at a Fraction of the Cost of Celebrity Diets 3
... Dec. 17 The holiday season is a,great opportunity to ... focus on new goals for the next 12 months. These ... with the,knowledge to become a healthy new you in 2008., ... get healthier is,the best gift you can give yourself this ...
... chronic pain are the leading causes of soldier attrition in ... percent when these soldiers are treated outside the theaters of ... and officers are treated and managed for pain in the ... to a new study from a Johns Hopkins anesthesiologist. , ...
... novel surgical technique allowing doctors to operate on ... stomach could potentially replace certain types of conventional ... researchers who have successfully demonstrated the procedure in ... in human trials, researchers say it could circumvent ...
... without diet changes, study finds , , MONDAY, Dec. 17 (HealthDay ... week is enough to undo metabolic syndrome, a health condition ... new study suggests. , "What we found was a modest ... metabolic syndrome risk," said study author Johanna L. Johnson, a ...
... Two recently released studies confirm an alarming reality, ... screened for colorectal cancer are not. Men and women ... colorectal cancer, but according to a study in the ... Medicare beneficiaries between 1998 and 2004, only 25.4 percent ...
... Congressman John P. Murtha, Chairman of the House Appropriations Subcommittee ... on behalf of veterans blinded by war and for research ... year the Institute gives the Man of Vision Award to ... and the awareness of the challenges of vision loss. Among ...
Cached Medicine News:Health News:AMA: Resolutions for a Healthy New You in the New Year 2Health News:Pain treatment in the field: Good for soldiers' comfort and better for rebuilding troop strength 2Health News:Z-shaped incision enhances minimally-invasive surgery 2Health News:Z-shaped incision enhances minimally-invasive surgery 3Health News:Moderate Exercise Cuts Risk of Metabolic Syndrome 2Health News:Moderate Exercise Cuts Risk of Metabolic Syndrome 3Health News:Recent studies confirm significant underuse of colorectal cancer screening 2Health News:Recent studies confirm significant underuse of colorectal cancer screening 3Health News:Champion of blinded soldiers, Congressman Murtha, is Man of Vision 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: